Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
The drugmaker has received approval from the Hong Kong government to sell its tirzepatide injections — branded as Mounjaro — ...
The global injection pen market is expanding at a fast rate with the growing prevalence of chronic diseases, and increasing demand for convenient self-administration options. This trend is a move ...
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among patients in a clinical trial, new data reported Tuesday show.
Eli Lilly’s third-quarter sales and earnings were lower than expected, a rare stumble for the company that had consistently reported strong sales and beat earnings forecasts since demand for its ...
Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter vials. The company said new regulations had led to a brief delay in manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback